ICD-10-CM Diagnosis Code A22.2: Gastrointestinal anthrax 

A22.2

A22.2 is a billable and specific ICD-10-CM Diagnosis code for Gastrointestinal anthrax.

Accurate documentation of A22.2 facilitates proper diagnosis, effective management, and ensures correct insurance billing. Moreover, it supports public health efforts and enables accurate reimbursement.

Purpose of This Guideline

This guideline explains:

  • The official use of A22.2
  • ICD-10-CM coding guidelines
  • The historical background of this diagnosis code

What is the ICD-10-CM Diagnosis Code for Gastrointestinal anthrax ?

The ICD-10-CM diagnosis code for Gastrointestinal anthrax is A22.2

Anthrax is a serious infectious disease caused by the bacterium Bacillus anthracis. It can affect the skin, lungs, or digestive system. Typically, the disease spreads through contact with infected animals or animal products.

In the case of gastrointestinal anthrax, infection occurs after ingesting undercooked or contaminated meat containing anthrax spores. 

Once the spores enter the digestive system, they infect the stomach and intestines. As a result, the disease can progress rapidly if left untreated.

Signs and Symptoms

Initially, symptoms of gastrointestinal anthrax may resemble common stomach infections. However, the condition can become critical within a short time.

For example, early signs may include:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Fever

Later, more serious symptoms can emerge, such as:

  • Severe diarrhea
  • Swelling of the neck
  • Difficulty swallowing
  • Blood in stool

Therefore, early detection is essential to avoid complications. In many cases, the disease can become life-threatening without prompt treatment.

Diagnosis and Treatment

To diagnose the condition, healthcare providers may use:

  • Stool tests
  • Blood cultures
  • Abdominal imaging

After confirmation, treatment should begin immediately. Fortunately, the infection responds well to early antibiotic therapy.

Common medications include:

  • Ciprofloxacin
  • Doxycycline
  • Combination therapies for critical cases

In addition, patients may need supportive treatments such as IV fluids or hospitalization. Consequently, timely intervention improves outcomes.

History Background of ICD-10-CM Diagnosis Code A22.2

The ICD-9-CM system, first introduced in 1979, provided the initial framework for coding diseases and health-related conditions in the United States.

Originally, The ICD-9-CM diagnosis code for  Gastrointestinal anthrax was 022.2.This coding remained consistent from 1979 to 2015.

While the ICD-9-CM system offered a basic approach to disease classification, modern healthcare needs more detail and specificity.

Therefore, the ICD-10-CM system was launched in 2015. It provided expanded categories and better disease tracking.

The transition from ICD-9-CM to ICD-10-CM significantly improved the ability to document and analyze conditions such as  Gastrointestinal anthrax.

The 2025 edition of ICD-10-CM A22.2 became effective on October 1, 2024.

YearICD-10-CM CodeDescription
2020A22.2No Change
2021A22.2No Change
2022A22.2No Change
2023A22.2No Change
2024A22.2No Change
2025A22.2No Change

Why Accurate Documentation Using A22.2 Matters

Proper coding, like A22.2, supports:

  • Timely and accurate diagnosis
  • Immediate treatment decisions
  • Well-maintained medical records
  • Efficient insurance processing
  • Reliable health data reporting

In addition, using the correct code helps reduce errors and delays. Furthermore, it improves hospital workflows and public health tracking.

Other ICD-10-CM Diagnosis Codes in A22

ICD-10-CM code A22 | Anthrax has following sub categories including A22.2 :

  • A22 Anthrax.
  •  A22.0 Cutaneous anthrax.
  •  A22.1 Pulmonary anthrax.
  •  A22.2 Gastrointestinal anthrax.
  •  A22.7 Anthrax sepsis.
  •  A22.8 Other forms of anthrax.
  •  A22.9 Anthrax, unspecified.

Final Thoughts

In conclusion, accurate use of A22.2 is critical for identifying and managing Gastrointestinal anthrax. A clear understanding of its history, and correct usage enhances medical documentation and ensures effective treatment, patient care, supports healthcare planning, and guarantees proper reimbursement for medical services.

About Author
content writer
Dr. Sehrish Bano, CPB & CPC

As a certified professional in both billing and coding, I specialize in streamlining healthcare revenue cycles and ensuring accurate claim submissions. With more than five years of experience serving the healthcare industry in the USA, I bring expertise in coding accuracy, compliance, and reimbursement optimization. My work focuses on reducing errors, improving efficiency, and supporting providers in delivering quality care without administrative hurdles. I am committed to helping healthcare organizations achieve financial stability and compliance through reliable billing and coding practices.

Table of Contents